Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition - O'Neill : O'Neill

Journal of the American Medical Association | February 22, 2024

Read the Publication

Latest publications See All

Op-Ed

January 9, 2025

A Turning Point in Public Health

Op-Ed

January 9, 2025

American Global Health Leadership in a Second Trump Administration

Quick Take

January 7, 2025

HIV and Hepatitis C Prevention in Opioid Response Initiatives